Related Experiment Video
Updated: Apr 5, 2026

Generation of Ventricular-Like HiPSC-Derived Cardiomyocytes and High-Quality Cell Preparations for Calcium Handling Characterization
Published on: January 17, 2020
Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells
Atsushi Tanaka1, Shinsuke Yuasa2, Koichi Node3
1Department of Cardiovascular Medicine, Saga University, 5-1-1 Nabeshima, Saga 849-8501, Japan. tanakaa2@cc.saga-u.ac.jp.
Induced pluripotent stem cells (iPSCs) offer a revolutionary tool for studying genetic disorders. Disease-specific iPSC-derived cardiomyocytes are advancing cardiovascular disease research and drug discovery.
Area of Science:
- Regenerative Medicine
- Stem Cell Biology
- Cardiovascular Research
Background:
- Induced pluripotent stem cells (iPSCs) provide patient-specific cells for disease modeling.
- Genetic disorders can be studied using iPSCs derived from affected individuals.
- iPSCs retain the genetic anomalies of the donor, making them valuable research tools.
Purpose of the Study:
- To review recent advancements in cardiovascular disease modeling using iPSCs.
- To discuss the challenges and future directions of iPSC technology in cardiology.
Main Methods:
- Modeling of cardiovascular diseases using iPSC-derived cardiomyocytes.
- Analysis of pathophysiological cellular phenotypes in vitro.
- Review of current literature on iPSC applications in cardiovascular research.
Main Results:
- iPSC technology enables the creation of in vitro models for genetic heart diseases like arrhythmias and cardiomyopathies.
- Disease-specific iPSC-derived cardiomyocytes allow for detailed study of cellular mechanisms.
- These models show promise for novel drug discovery and understanding disease progression.
Conclusions:
- iPSC-derived cardiomyocytes are a powerful platform for modeling cardiovascular diseases.
- Further research is needed to overcome current limitations and fully realize the potential of iPSCs in medicine.
- iPSC technology is poised to significantly impact cardiovascular research and therapeutic development.
More Related Videos
05:06Model of Ischemic Heart Disease and Video-Based Comparison of Cardiomyocyte Contraction Using hiPSC-Derived Cardiomyocytes
Published on: May 5, 2020
13:18Generation of Human Cardiomyocytes: A Differentiation Protocol from Feeder-free Human Induced Pluripotent Stem Cells
Published on: June 28, 2013
Related Concept Videos
EPS and iPS Cells in Disease Research
Induced Pluripotent Stem Cells
Induced Pluripotent Stem Cells
Somatic...
Induced Pluripotent Stem Cells
iPS Cell Differentiation
Stem Cell Culture